Eupraxia Pharmaceuticals
- Market cap
- 514.05M
- P/E (TTM)i
- -7.63
- P/Bi
- 5.05
- EPSi
- -1.03
- Div yieldi
- 0.00%
- 52W posi
- 62%
Anonymous reader poll. Unscientific, not investment advice.
Eupraxia Pharmaceuticals shares were changing hands at 7.78, up 0.52% on the day. Its market capitalisation is about 514.05M, the #3732 most valuable US-listed company we track. The 8 analysts covering the stock are, on balance, at Buy, targeting an average of 17.00 (+119%). The shares sit 62% of the way up their 52-week range of 5.25 to 9.32.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Price momentum averages +23.1% across the trailing 3-month/1-year windows.
- Analyst consensus across 8 analysts is Buy.
- Recent price momentum is +23.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 11.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 7.74
- Open
- 7.64
- Day range
- 7.48 - 7.88
- Avg price
- 7.69
- Volume
- 853.31K
- Turnover
- 6.56M
- Turnover ratei
- 1.53%
- Volume ratioi
- 0.42
- Amplitudei
- 5.23%
- 52-week rangei
- 5.25 - 9.32
Valuation
- P/Ei
- -7.55
- P/E (TTM)i
- -7.63
- P/Bi
- 5.05
- EPSi
- -1.03
- Book value / shi
- 1.54
- Net profit
- -68.06M
- Net assets
- 101.75M
Share structure
- Market cap
- 514.05M
- Float capi
- 434.40M
- Shares out
- 66.07M
- Float sharesi
- 55.84M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
16.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-18.85M net over the window
Short interest
- Shares short
- 7.58M
- % of floati
- 11.48%
- Days to coveri
- 11.25
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Eupraxia Pharmaceuticals (EPRX)?
Eupraxia Pharmaceuticals last traded at 7.78. The quote on this page refreshes every few seconds while US markets are open.
What is Eupraxia Pharmaceuticals's market cap?
About 514.05M.
What is the P/E ratio of Eupraxia Pharmaceuticals?
The trailing twelve-month P/E is -7.63. The Valuation tab shows it against the stock's own five-year range.
Does Eupraxia Pharmaceuticals pay a dividend?
Eupraxia Pharmaceuticals does not currently pay a regular dividend.
Is Eupraxia Pharmaceuticals a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 17.00, which implies 118.5% upside from the current price. This is not investment advice.
Quote time 2026-10-08 08:09:00 · For reference only, not investment advice and not tailored to your situation.